Anxiety
- Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug (PubMed)
- Antidepressant-Like and Anxiolytic-Like Effects of Cannabidiol: A Chemical Compound of Cannabis Sativa (PubMed)
- Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients (PubMed)
- Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder(PubMed)
- Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation (PubMed)
- Effects of cannabidiol (CBD) on regional cerebral blood flow (PubMed)
- The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors (PubMed)
- The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system (PubMed)
- Plant-based medicines for anxiety disorders, part 2: A review of clinical studies with supporting preclinical evidence (PubMed)
- Action of Cannabidiol on the Anxiety and Other Effects Produced by Δ9-THC in Normal Subjects (Psychopharmacology)
- Antidepressant-Like and Anxiolytic-Like Effects of Cannabidiol: A Chemical Compound of Cannabis sativa (Bentham Science)
- Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug ( Brazilian Psychiatric Association)
- Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives (National Institute of Health)
- Chronic blockade of cannabinoid CB2 receptors induces anxiolytic-like actions associated with alterations in GABAA receptors (British Journal of Pharmacology)
- Effects of Cannabidiol (CBD) on Regional Cerebral Blood Flow (Neuropsychopharmacology)
- Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing (American Medical Association)
- Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report (Journal of Psychopharmacology)
- Cannabinoid CB1 receptors in the dorsal hippocampus and prelimbic medial prefrontal cortex modulate anxiety-like behavior in rats: Additional evidence (ScienceDirect)